Mast cells in irritable bowel syndrome and ulcerative colitis: Function not numbers is what makes all the difference

Digestive Diseases and Sciences

Volumn 59, Issue 5, 2014, Pages 897-898

  Theoharides, Theoharis C ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE DECARBOXYLASE; TRYPTASE;

BACTERIUM ADHERENCE; CD3+ T LYMPHOCYTE; CHRONIC STRESS; COLON BIOPSY; DEGRANULATION; EDITORIAL; GENE EXPRESSION; HUMAN; IRRITABLE COLON; LAMINA PROPRIA; MAST CELL; PRIORITY JOURNAL; REMISSION; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLON; FEMALE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE;

EID: 84899930921     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2988-z     Document Type: Editorial

References (14)

1. Rijnierse A, Koster AS, Nijkamp FP, Kraneveld AD. TNF-alpha is crucial for the development of mast cell-dependent colitis in mice. Am J Physiol Gastrointest Liver Physiol. 2006;291:G969-G976. (Pubitemid 44772023)
2. Braak B, Klooker TK, Wouters MM, et al. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? Am J Gastroenterol. 2012;107:715-726.
3. Ahn YJ, Lee KH, Choi CH, et al. Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis. Dig Dis Sci. 2013. (Epub ahead of print). doi:10.1007/s10620-013-2930-4.
4. Theoharides TC, Asadi S, Chen J, Huizinga JD. Irritable bowel syndrome and the elusive mast cells. Am J Gastroenterol. 2012;107:727-729.
5. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007;217:65-78. (Pubitemid 46718152)
6. Kiank C, Tache Y, Larauche M. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav Immun. 2010;24:41-48.
7. Santos J, Benjamin M, Yang PC, Prior T, Perdue MH. Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells. Am J Physiol Gastrointest Liver Physiol. 2000;278:G847-G854. (Pubitemid 30439162)
8. Theoharides TC, Letourneau R, Patra P, et al. Stress-induced rat intestinal mast cell intragranular activation and inhibitory effect of sulfated proteoglycans. Dig Dis Sci. 1999;44:87S-93S. (Pubitemid 29450797)
9. Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC, Rivier J. Key Role of CRF in the Skin Stress Response System. Endocr Rev. 2013;34:827-884.
10. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci. 2004;25:563-568. (Pubitemid 39371146)
11. Vanuytsel T, van Wanrooy S, Vanheel H, et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut. 2013. (Epub ahead of print). doi:10.1136/gutjnl-2013-305690.
12. Soderholm JD, Yang PC, Ceponis P, et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology. 2002;123:1099-1108.
13. Theoharides TC. Atopic conditions in search of pathogenesis and therapy. Clin Ther. 2013;35:544-547.
14. Kempuraj D, Tagen M, Iliopoulou BP, et al. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells. Br J Pharmacol. 2008;155:1076-1084.